In 2025, Huangpu Customs Records a 20.6% Year-on-Year Increase in Export Value of Medical Devices

As society develops and health awareness continues to rise, international demand for high-end medical devices—particularly in areas such as cardiovascular and cerebrovascular interventional devices and respiratory therapy—has remained strong. Domestic medical device manufacturers have seized these opportunities and accelerated their expansion into overseas markets.
According to statistics, in 2025, Huangpu Customs supervised and cleared exports of medical devices such as hearing aids and respiratory equipment with a total value of 2.18 billion yuan, representing a year-on-year increase of 20.6%.

Changping Customs, under Huangpu Customs, conducted inspections on imported medical device components for a medical technology company within its jurisdiction.

Dongguan Qiushi Electronic Technology Co., Ltd. is among the early enterprises to expand into overseas markets. “Our hybrid vascular treatment catheter production line utilizes microscopic assembly technology to achieve precise coordination between manual and automated processes, enabling the accurate assembly of micro-sensing medical devices such as cardiac sensors and balloon catheters, which are well received in international markets,” said Wang Shujun, the company’s customs affairs manager. “In 2025, our export value reached 840 million yuan, up 127.3% year on year.”

To facilitate the efficient and secure customs clearance of medical devices, Huangpu Customs has taken compliance management as a core approach to providing targeted support to enterprises. The customs authority has proactively carried out policy guidance, organized briefing sessions, and explained declaration requirements to help medical device enterprises accurately understand the classification and value declaration of high-end and sophisticated products. At the same time, it regularly informs enterprises of updates such as the EU’s general performance requirements and new regulations issued by the U.S. FDA, organizes expert assessments on their impact on product performance and safety standards, and promotes a shift in enterprise compliance management from post-issue remediation to proactive planning.

In addition, Huangpu Customs has developed an AEO cultivation and certification roadmap, providing dedicated training and simulated on-site certification guidance to help medical device enterprises comprehensively enhance their management capabilities across four key areas: internal control, financial status, compliance with laws and regulations, and trade security.